LEHI, UTAH / ACCESSWIRE / November 12, 2019 / Frelii, Inc. (OTC PINK:FRLI) ("Frelii" or the "Company"), a biotechnology company working to commercialize its patent-pending DNA gene sequencing ...
Presenting Author: Sharat Singh, PhD, Head of Research, Biora Therapeutics, Inc. About the BioJet™ Systemic Oral Delivery PlatformBiora's BioJet systemic oral therapeutics platform uses an ingestible ...
BEERSE, Belgium--(BUSINESS WIRE)--The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the European Commission (EC) has granted marketing authorisation for the expanded use of ...
Buccal drug delivery systems represent an innovative strategy for the administration of therapeutic agents via the oral mucosa. This approach bypasses the hepatic first‐pass metabolism, thereby ...
PK studies of topical HT-001 reveal limited systemic absorption and ~99% reduced systemic levels as compared to FDA approved oral formulations. Safety and tolerability findings included: No serious ...
The 4 th Nasal Formulation & Delivery Summit is a specialist meeting focused on the formulation, delivery, and regulatory challenges of intranasal therapeutics. This guide covers device innovation, ...
Dr. Singh will also participate in a panel discussion on June 19 at 8:45 AM titled “Uncovering Innovations in Peptide Drug Delivery & Formulation for Improved Bioavailability,” alongside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results